{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-122229","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.561253+00:00","generated_at":"2026-05-30T04:28:24.579673+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.72,"calibrated_materiality_score":0.72,"confidence":"high","headline":"Outset Medical Q3 revenue $28.7M, net loss $0.55/share; raises FY2024 revenue guidance to ~$112M","bullets":["Revenue $28.7M down 6% YoY but up 5% QoQ; product revenue $20.3M down 14% YoY.","Recurring revenue (cartridges + service) $21M, up 17% YoY; gross margin 34.3% vs 23.6% YoY.","Net loss $27.9M ($0.55/share) vs $46.2M ($0.93/share) in Q3 2023; non-GAAP net loss $20.2M ($0.39/share).","FY2024 revenue guidance raised to ~$112M from ~$110M; non-GAAP gross margin guided to mid-30% range.","Cash & investments $179.0M as of Sept 30, 2024; operating expenses down 36% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-122229","json":"https://secwatch.observer/filing/0000950170-24-122229.json","markdown":"https://secwatch.observer/filing/0000950170-24-122229.md","text":"https://secwatch.observer/filing/0000950170-24-122229.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000095017024122229/0000950170-24-122229-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000095017024122229/om-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:28:24.579673+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}